COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA (CAP) explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA (CAP) trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pneumonia drug trial aims to protect arteries from hidden damage
Disease control Recruiting nowThis study tests whether a drug called icosapent ethyl (Vascepa) can reduce inflammation in the arteries of people hospitalized with pneumonia. Pneumonia can trigger body-wide inflammation that may harm blood vessels. Researchers will give 168 adults either Vascepa or a placebo t…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
ER study aims to cut unnecessary antibiotics for kids with pneumonia
Disease control Recruiting nowThis study looks at whether a new approach can safely reduce antibiotic use in children aged 6 months to 18 years who have mild pneumonia and are sent home from the emergency room. About 700 children will take part. The goal is to give antibiotics only when truly needed, while st…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Jeffrey Pernica • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Which steroid works best for severe pneumonia? major trial aims to find out
Disease control Recruiting nowThis study compares two common steroids, hydrocortisone and prednisolone, in 1,600 adults hospitalized with severe community-acquired pneumonia. The goal is to see which one reduces deaths within 30 days. Participants are randomly assigned to one of the two treatments.
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE4 • Sponsor: Copenhagen Respiratory Research • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a 'Wait and See' approach cut antibiotic overuse in kids with pneumonia?
Disease control Recruiting nowThis study compares two ways of giving antibiotics to children with mild pneumonia: giving them right away versus waiting 72 hours to see if symptoms improve. The goal is to see if the 'watch and wait' approach can safely reduce unnecessary antibiotic use. About 2,000 children wi…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to curb antibiotic overuse for coughs and colds
Knowledge-focused Recruiting nowThis study tests whether a two-part approach—improving communication about viral infections and having pharmacists double-check prescription lengths—can reduce how many days antibiotics are prescribed for respiratory infections like bronchitis, sinusitis, and sore throat. About 4…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New registry aims to unlock pneumonia mysteries in vulnerable patients
Knowledge-focused Recruiting nowThis study is observing about 1,300 hospitalized adults with weakened immune systems who have pneumonia. Researchers will track their health for one year, looking at causes, treatments, and outcomes. The goal is to gather information to improve care for this high-risk group.
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Sponsor: Societa Italiana di Pneumologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC